Souders Financial Advisors Teva Pharmaceutical Industries LTD Transaction History

Souders Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$8.38 - $10.18 $702,419 - $853,297	-83,821 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$9.9 - $11.56 $97,703 - $114,085	9,869 Added 13.35%	83,821 $830,000
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $49,621 - $61,475	4,799 Added 6.94%	73,952 $853,000
Q4 2020 Feb 09, 2021	BUY	$8.61 - $11.04 $40,045 - $51,347	4,651 Added 7.21%	69,153 $667,000
Q3 2020 Nov 12, 2020	BUY	$8.57 - $12.69 $42,207 - $62,498	4,925 Added 8.27%	64,502 $621,000
Q2 2020 Aug 11, 2020	BUY	$8.12 - $13.12 $131,673 - $212,753	16,216 Added 37.4%	59,577 $735,000
Q1 2020 May 12, 2020	BUY	$6.69 - $13.45 $290,085 - $583,205	43,361 New	43,361 $389,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Souders Financial Advisors with notifications on news.